Phase (Ph) 1 2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev - TSR - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-06-03 16:42:55		Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev Add to Reading List Source URL: www.tesarobio.com Download Document from Source Website File Size: 959,07 KB Share Document on Facebook